期刊名称:Proceedings of the National Academy of Sciences
印刷版ISSN:0027-8424
电子版ISSN:1091-6490
出版年度:1978
卷号:75
期号:5
页码:2416-2420
DOI:10.1073/pnas.75.5.2416
语种:English
出版社:The National Academy of Sciences of the United States of America
摘要:The alternative or properdin pathway of complement is primarily controlled by the endopeptidase C3b inactivator (C3bINA) and the nonproteolytic glycoprotein {beta}1H. The molecular mechanisms of control were investigated by performing binding studies of radiolabeled complement proteins to C3b bearing sheep erythrocytes (ESC3b). C3b was found to have distinct binding sites for {beta}1H, C3bINA, Factor B, and properdin. {beta}1H binding increased C3bINA binding 30-fold, while Factor B binding prevented C3bINA action on C3b and was competitive with {beta}1H binding. Properdin binding, which facilitates Factor B interaction with C3b, had no effect on the {beta}1H and C3bINA sites. Activators such as rabbit erythrocytes (ER) have previously been shown to interfere with the effectiveness of the control by C3bINA and {beta}1H, thereby allowing unrestricted formation of C3 convertase. Such restriction of control does not occur on the surface of ES, a nonactivator of the alternative pathway. On the basis of comparative binding studies, restriction of control is explained entirely by reduced binding of {beta}1H to ERC3b relative to ESC3b. Access of properdin, Factor B, C3bINA, and the Fab fragment of anti-C3 to the two cell types was unrestricted. Restriction of {beta}1H control could be generated on the surface of ES by removal of cell-surface sialic acid with neuraminidase (acylneuraminyl hydrolase; EC 3.2.1.18 ). This enzymatic treatment converted ES from a nonactivator to an activator of the alternative pathway.